Clearstead Advisors’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-683
Closed -$29.1K 3252
2025
Q2
$29.1K Buy
683
+415
+155% +$17.3K ﹤0.01% 1473
2025
Q1
$12K Hold
268
﹤0.01% 1566
2024
Q4
$14.7K Hold
268
﹤0.01% 1475
2024
Q3
$11.3K Hold
268
﹤0.01% 1560
2024
Q2
$12.3K Buy
+268
New +$12.6K ﹤0.01% 1505

Other funds holding VCEL

Clearstead Advisors's VCEL Position: Q3 2025 in Review

Clearstead Advisors sold out of Vericel Corp (VCEL) in Q3 2025, closing a stake of 683 shares — an estimated $29.1K sold.

Clearstead Advisors first reported a position in VCEL in Q2 2024 and held it in 5 quarters. The position peaked at $29.1K in Q2 2025. 249 funds tracked by Wall St. Rank hold VCEL as of Q3 2025.

  • Clearstead Advisors reported no remaining Vericel Corp position as of Q3 2025 after selling out during the quarter.
  • Clearstead Advisors sold 683 Vericel Corp shares in Q3 2025, an estimated $29.1K.
  • Clearstead Advisors first reported a position in Vericel Corp in Q2 2024 and held it in 5 quarters.
  • Clearstead Advisors's Vericel Corp position peaked at $29.1K in Q2 2025.
  • 249 funds tracked by Wall St. Rank held Vericel Corp as of Q3 2025.

Based on Clearstead Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.